Millets are genuinely anti-inflammatory foods for joint health, supported by robust biochemical evidence of their polyphenolic compounds' ability to suppress multiple inflammatory pathways simultaneously. Key anti-inflammatory mechanisms include COX-2 inhibition (sorghum anthocyanidins), NF-κB pathway suppression (foxtail millet flavonoids), prostaglandin E2 reduction (pearl millet omega-3s), and TNF-α downregulation (finger millet tannins). What makes millets particularly valuable for joint health is that their anti-inflammatory activity is sustained throughout digestion, with bioactive compounds reaching synovial tissue through the bloodstream. A systematic review in MDPI (2023) confirmed that polyphenol-rich diets consistent with millet consumption patterns reduced serum CRP (C-reactive protein) — a primary inflammatory marker — by 20–30%.
Key Points
Sorghum: COX-2 inhibition comparable to NSAIDs — reduces prostaglandin-mediated joint pain without gastrointestinal toxicity
Foxtail millet: NF-κB suppression reduces production of destructive matrix metalloproteinases (MMPs) that degrade joint cartilage
Pearl millet ALA (omega-3): reduces leukotriene B4 production — a potent driver of neutrophil-mediated joint inflammation
Finger millet tannins: reduce TNF-α and IL-6 levels in serum, reducing systemic inflammation that worsens joint disease
Prebiotic fiber: reduces gut permeability (leaky gut), decreasing systemic LPS-driven inflammation that worsens autoimmune joint conditions
Evidence Base
MDPI Separations (2023) and Springer Nature Discover Food (2024) provide comprehensive evidence that millets reduce CRP and inflammatory cytokines by 20–30%, equivalent to mild anti-inflammatory pharmaceutical interventions and relevant for arthritis management.
© 2023 - 2026 Millets News. All rights reserved.